Atlas Trials

Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus Esophageal

Clinical trial NCT03584308 · COMPLETED

Trial details

NCT number
NCT03584308
Sponsor
Catalysis SL
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Papilloma Viral InfectionPapillomavirus InfectionsEsophageal Viral WartEsophageal Verrucous Carcinoma
Start date
2015-10-15
Primary completion
2018-05-15
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.